205 related articles for article (PubMed ID: 23699602)
1. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
2. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
3. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
4. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.
Chen K; Febbraio M; Li W; Silverstein RL
Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
[TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation.
Oh MJ; Zhang C; LeMaster E; Adamos C; Berdyshev E; Bogachkov Y; Kohler EE; Baruah J; Fang Y; Schraufnagel DE; Wary KK; Levitan I
J Lipid Res; 2016 May; 57(5):791-808. PubMed ID: 26989083
[TBL] [Abstract][Full Text] [Related]
7. Pyk2 downstream of G
Chaudhary PK; Han JS; Jee Y; Lee SH; Kim S
Biochem Biophys Res Commun; 2020 Jun; 526(3):738-743. PubMed ID: 32265034
[TBL] [Abstract][Full Text] [Related]
8. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.
Roberts W; Magwenzi S; Aburima A; Naseem KM
Blood; 2010 Nov; 116(20):4297-306. PubMed ID: 20664056
[TBL] [Abstract][Full Text] [Related]
10. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
11. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages.
Park YM
BMB Rep; 2015 Jan; 48(1):48-53. PubMed ID: 25322953
[TBL] [Abstract][Full Text] [Related]
13. Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.
Getz TM; Dangelmaier CA; Jin J; Daniel JL; Kunapuli SP
J Thromb Haemost; 2010 Oct; 8(10):2283-93. PubMed ID: 20670370
[TBL] [Abstract][Full Text] [Related]
14. Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway.
Signorello MG; Leoncini G
Biochimie; 2014 Oct; 105():182-91. PubMed ID: 25068972
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.
Zimman A; Titz B; Komisopoulou E; Biswas S; Graeber TG; Podrez EA
PLoS One; 2014; 9(1):e84488. PubMed ID: 24400094
[TBL] [Abstract][Full Text] [Related]
16. Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents.
Riondino S; Lotti LV; Cutini L; Pulcinelli FM
J Biol Chem; 2005 Feb; 280(8):6504-10. PubMed ID: 15598663
[TBL] [Abstract][Full Text] [Related]
17. The critical role of myosin IIA in platelet internal contraction.
Johnson GJ; Leis LA; Krumwiede MD; White JG
J Thromb Haemost; 2007 Jul; 5(7):1516-29. PubMed ID: 17488351
[TBL] [Abstract][Full Text] [Related]
18. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.
Murthy KS; Zhou H; Grider JR; Brautigan DL; Eto M; Makhlouf GM
Biochem J; 2003 Aug; 374(Pt 1):145-55. PubMed ID: 12733988
[TBL] [Abstract][Full Text] [Related]
19. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
20. The mechanism by which RhoA regulates vascular reactivity after hemorrhagic shock in rats.
Li T; Fang Y; Yang G; Zhu Y; Xu J; Liu L
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H292-9. PubMed ID: 20472763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
